400mg Abevmy Bevacizumab Injection

400mg Abevmy Bevacizumab Injection Specification

Pacakaging (Quantity Per Box)
1 Vial

Dosage Form
Liquid

Brand Name
Abevmy

Indication
Various cancers as specified in the prescribing information

Life Span
Check expiry date on the packaging

Origin of Medicine
India

Salt Composition
Bevacizumab 400mg/16ml

Packaging Type
Vial

Drug Type
Prescription

Ingredients
Bevacizumab

Physical Form
Injection

Function
Anti-cancer therapy (Monoclonal antibody - VEGF inhibitor)

Recommended For
Cancer (colorectal, lung, kidney, cervical, ovarian, and glioblastoma tumors)

Dosage
As directed by the physician

Dosage Guidelines
Administered as an intravenous infusion

Suitable For
Adults

Storage Instructions
Store in a refrigerator (2C - 8C). Do not freeze.

Prescription/Non-Prescription
Prescription Only

Common Side Effects
Hypertension, bleeding, proteinuria, infusion-related reactions, gastrointestinal perforations

Stability After Opening
Use immediately after dilution/preparation; otherwise refer to insert

Route of Administration
Intravenous

Appearance
Clear to slightly opalescent, colorless to pale brownish liquid

Infusion Time
First infusion over 90 minutes; subsequent as per physician's guidance

Storage Conditions
Protect from light. Keep out of reach of children.

Preparation Strength
400 mg/16 ml (25 mg/ml)

Therapeutic Class
Antineoplastic

Marketed By
Biocon Biologics

Contraindications
Hypersensitivity to Bevacizumab or any inactive ingredient

400mg Abevmy Bevacizumab Injection Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
7 Days

About 400mg Abevmy Bevacizumab Injection

Strength	400mg
Manufacturer	Mylan
Packaging Type	Box
Brand	Abevmy
Packaging Size	16ml
Composition	Bevacizumab
Treatment	Cancer

Bevacirel 400mg Injection is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.

It is an effective medicine, first-line option when used together with other cancer medicines. It is given as an infusion. That means you get it through a small needle in your vein or through a port, which is a device placed under your skin. Doctor will decide your dose and duration and will check you for signs of an infusion reaction such as high blood pressure and trouble breathing. You keep taking Bevacirel 400mg Injection as long as your disease is controlled and your side effects are manageable. Your doctor will determine whether you should stop taking it or not. You may be advised to check blood pressure and levels of protein in urine while you are taking this medication.

It may lower your wound healing ability, so inform your doctor that you are taking this medication before undergoing any surgical procedure. It may also increase your risk of bleeding thus if you notice any unusual bleeding or bleeding that does not stop than contact doctor immediately.

Powerful Cancer Therapy

Abevmy (Bevacizumab) delivers targeted anti-cancer action by inhibiting vascular endothelial growth factor (VEGF). This mechanism hinders the supply of nutrients to tumors, slowing growth in several cancer types. Its clinical use is guided by an oncologist, ensuring optimized therapy and patient safety.

Proper Administration and Dosage

This medication is administered intravenously, with the first infusion typically lasting 90 minutes. Dosage strength stands at 400mg in a single-use vial, and subsequent infusions are tailored by your healthcare provider. Always prepare and administer under supervision in a medical setting.

Handling, Stability, and Storage

Once prepared, Abevmy should be used immediately unless otherwise directed in the package insert. The vial must be stored in a refrigerator (2C to 8C), protected from light, and never frozen. Refer to the expiry date on the package before use, and keep it out of reach of children.

FAQ's of 400mg Abevmy Bevacizumab Injection:

Q: How should Abevmy Bevacizumab Injection be administered?

A: Abevmy is administered as an intravenous infusion, with the first infusion typically lasting 90 minutes. Subsequent infusions and dosing intervals are directed by your physician based on your medical condition and response.

Q: What types of cancer is Abevmy Injection typically used to treat?

A: Abevmy Bevacizumab Injection is recommended for adult patients with cancers such as colorectal, lung, kidney, cervical, ovarian, and glioblastoma tumors. Its use is only as specified in the prescribing information and under a physician's supervision.

Q: When should Abevmy be used after preparation or dilution?

A: After dilution or preparation, Abevmy should be used immediately to maintain its stability. If immediate use is not possible, please refer to the detailed storage and handling instructions provided in the product insert.

Q: Where should Abevmy Injection be stored before administration?

A: Store the unopened vial in a refrigerator between 2C and 8C, protected from light. Do not freeze the solution, and ensure it is kept out of reach of children.

Q: What is the benefit of using Abevmy in cancer therapy?

A: Abevmy targets VEGF, preventing the growth of blood vessels that supply tumors, ultimately limiting tumor growth. This targeted approach can enhance the effectiveness of treatment in several cancer types under medical supervision.

Q: What common side effects might occur with Abevmy treatment?

A: Some common side effects include hypertension (high blood pressure), bleeding, proteinuria (protein in the urine), infusion-related reactions, and gastrointestinal perforations. Any unusual symptoms should be reported to your healthcare provider promptly.

Q: Who should avoid using Abevmy Injection?

A: Those with hypersensitivity to Bevacizumab or any of the injection's ingredients should not use Abevmy. Ensure to discuss your full medical history and allergies with your oncologist before beginning treatment.